Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral Administration
Advanced Materials · 2025
DOI: 10.1002/adma.202500495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Nan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal Un…. Hauptthemen laut MEDLINE: Mitochondria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Key Laboratory of Biofunctional Materials.
Abstract (Originalsprache)
Delivering energy in vivo is essential for treating mitochondrial damage‐related diseases. Current methods, including natural mitochondrial transplantation and artificial energy delivery systems, lack non‐destructive, external energy‐free, and clinically viable potential solutions. Here, artificial mitochondrial nanorobots (AMNs) carrying high‐energy phosphate bonds rebuild the in vivo energy supply system to provide energy. Using ischemic heart disease (IHD) as an energy‐deficient disease model and the oral route, which has high patient compliance and facilitates long‐term administration, to investigate the therapeutic efficacy of AMNs. AMNs remain stable in the gastrointestinal tract, cross the intestinal barrier via a barrier‐crossing unit, and target damaged heart tissue and cardiomyocytes using a motion unit chemotactically. Intracellularly, their energy‐generating unit provides high‐energy phosphate bonds for ATP synthesis (duration 12 h), while synergistically reducing inflammation and restoring cell viability. At the same frequency of administration, oral AMNs (50 mg kg −1 ) match intravenous AMNs (10 mg kg −1 ) in therapeutic efficacy, offering a convenient approach to improving cardiac function. Transcriptomics confirm that 200 µg AMNs emulate 5 × 10⁶ natural mitochondria, restoring energy metabolism and structural function in damaged hearts at the genetic level. This innovative design opens a new pathway for the construction of artificial energy delivery systems in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China.
- Department of Vascular Surgery, Cardiovascular Medical Center, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
ORCID-Profile: Chun Mao
Förderung
- National Natural Science Foundation of China
- Jiangsu Key Laboratory of Biofunctional Materials
Zitieren
APA
Li, N., Zhou, M., Wu, Z., Chen, Y., Duan, Y., Zhang, Z., Wu, Z., Xia, X., Shen, J., Mao, C., & Wan, M. (2025). Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral Administration. Advanced Materials. https://doi.org/10.1002/adma.202500495
Vancouver
Li N, Zhou M, Wu Z, Chen Y, Duan Y, Zhang Z, et al. Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral Administration. Advanced Materials. 2025. doi:10.1002/adma.202500495
BibTeX
@article{Li2025,
author = {Li, Nan and Zhou, Min and Wu, Ziyu and Chen, Yu and Duan, Yu and Zhang, Ziqiang and Wu, Zhuolin and Xia, Xue and Shen, Jian and Mao, Chun and Wan, Mimi},
title = {Artificial Mitochondrial Nanorobots Deliver Energy In Vivo by Oral Administration},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202500495}
}
EUVIMED